Following on from advice received from the company, NICE has decided to suspend this appraisal from its work programme whilst the company confirm their regulatory filing plans.
As this appraisal has been referred NICE will continue to monitor any development and will update interested parties if the situation changes.
| Status | Suspended |
| Technology type | Medicine |
| Decision | Selected |
| Process | STA Standard |
| ID number | 4053 |
Email enquiries
- If you have any queries please email scheduling@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 19 February 2024 | Suspended. Following on from advice received from the company, NICE has decided to suspend this appraisal from its work programme whilst the company confirm their regulatory filing plans. As this appraisal has been referred NICE will continue to monitor any development and will update interested parties if the situation changes. |
| 26 January 2024 | Please note that following on from advice received from the company this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, we now anticipate that the appraisal will begin during mid-April 2025 when we will write to you about how you can get involved. The deadline for submissions is expected in approximately late June 2025. |
| 12 January 2023 | Please note that, following discussion between NICE and the company, this appraisal will be rescheduled to align with NICE’s proportional approach to technology appraisals. The timelines for this appraisal are to be confirmed. |
For further information on our processes and methods, please see our CHTE processes and methods manual